A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,009,541 shares of RPRX stock, worth $24.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,009,541
Previous 993,578 1.61%
Holding current value
$24.5 Million
Previous $26.2 Million 9.0%
% of portfolio
0.02%
Previous 0.02%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$25.63 - $29.27 $409,131 - $467,237
15,963 Added 1.61%
1,009,541 $28.6 Million
Q2 2024

Jul 19, 2024

BUY
$26.26 - $29.9 $1.63 Million - $1.86 Million
62,218 Added 6.68%
993,578 $26.2 Million
Q1 2024

Apr 19, 2024

SELL
$27.46 - $31.33 $2.4 Million - $2.73 Million
-87,266 Reduced 8.57%
931,360 $28.3 Million
Q4 2023

Jan 30, 2024

SELL
$26.21 - $29.22 $7.5 Million - $8.36 Million
-286,133 Reduced 21.93%
1,018,626 $28.6 Million
Q3 2023

Oct 30, 2023

SELL
$26.26 - $31.38 $29,673 - $35,459
-1,130 Reduced 0.09%
1,304,759 $35.4 Million
Q2 2023

Jul 31, 2023

BUY
$29.6 - $36.56 $534,546 - $660,237
18,059 Added 1.4%
1,305,889 $40.1 Million
Q1 2023

Apr 27, 2023

BUY
$32.77 - $39.4 $9.16 Million - $11 Million
279,667 Added 27.74%
1,287,830 $46.4 Million
Q4 2022

Jan 30, 2023

BUY
$39.17 - $44.04 $13,435 - $15,105
343 Added 0.03%
1,008,163 $39.8 Million
Q3 2022

Oct 21, 2022

BUY
$39.88 - $44.65 $143,009 - $160,114
3,586 Added 0.36%
1,007,820 $40.5 Million
Q2 2022

Jul 26, 2022

BUY
$37.53 - $44.22 $3.14 Million - $3.69 Million
83,553 Added 9.08%
1,004,234 $42.2 Million
Q1 2022

Apr 27, 2022

BUY
$37.46 - $42.44 $34.5 Million - $39.1 Million
920,681 New
920,681 $35.9 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.